内陆帝国的儿童喘:环境负担,预防护理的差距和未满足的需求
Catherine Kim1, Christine Gharib1, Hani Atamna1
1California University of Science and Medicine, Colton, CA 92324, USA.
Children (Basel, Switzerland)
|September 27, 2025
概括
内陆帝国的儿童喘因空气污染和社会经济因素而恶化,导致更多的急诊室访问. 有针对性的干预措施对于改善这一弱势群体的健康结果至关重要.
科学领域:
- 环境健康 环境健康
- 儿科肺病学 儿科肺病学
- 健康差异 在健康上的差异
背景情况:
- 儿童喘是一个全球性的健康问题,严重影响儿童的健康和医疗保健系统.
- 南加州的内陆帝国 (IE) 地区面临着由于其独特的环境和社会经济因素而造成的儿童喘不成比例的负担.
- 在IE中对儿科喘的研究是有限的,这导致了持续的健康差异.
研究的目的:
- 检查内陆帝国儿科喘的环境和生活方式决定因素.
- 分析区域数据和文献,以了解IE内儿童喘负担的加重因素.
- 突出IE在喘研究中的代表性不足及其影响.
主要方法:
- 使用PubMed,Scopus和Google Scholar (2000-2025) 等数据库进行了叙事文献审查和区域数据分析.
- 来自公共卫生组织 (CDC,CDPH,美国肺部协会) 的数据被纳入.
- 关键词包括"儿科喘,内陆帝国,空气污染,喘差异,急诊室利用率,社会经济地位",具体的包含和排除标准适用于61个来源.
主要成果:
- 由于地理因素,IE包含高度污染的城市,车辆排放和工业废物集中在其中.
- 圣贝纳迪诺和里弗赛德县的儿童喘急诊室访问率超过了加利福尼亚州的平均水平.
- 在圣贝纳迪诺县,患有喘的幼儿 (0-4岁) 的住院率高于州平均水平.
结论:
- 儿童喘在IE的特点是环境风险很大,社会经济障碍和医疗保健的不足.
- 需要进行特定区域的研究和有针对性的干预措施,以解决空气质量,喘管理和预防性护理等问题.
- 政策变化和改善医疗保健准入对于缓解喘差异和改善IE儿童的长期结果至关重要.
关键词:
学术成就 学术成就空气污染 空气污染紧急部门利用率的使用率.医疗保健利用率 医疗保健利用率臭氧层中的臭氧.颗粒物质颗粒物质颗粒物质儿科喘 儿科喘 儿科喘虫害过敏原 虫害过敏原社会经济地位 社会经济地位更多相关视频
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10.8K
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
2.7K
相关概念视频
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Inhaled Medications
749
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
749
